Reaching the Nadir of Medication Overuse in Chronic Migraine

The introduction of new drug classes for chronic migraine, such as monoclonal antibodies for calcitonin-gene-related peptide or its receptor (CGRPr), or antagonists of the same CGRP, have opened a new scenario in a selected population of individuals with migraine, and those presenting with chronic f...

Descripción completa

Detalles Bibliográficos
Autores principales: Onan, Dilara, Wells-Gatnik, William David, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690126/
https://www.ncbi.nlm.nih.gov/pubmed/36429413
http://dx.doi.org/10.3390/ijerph192214696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690126/
https://www.ncbi.nlm.nih.gov/pubmed/36429413
http://dx.doi.org/10.3390/ijerph192214696

Ejemplares similares